Human Molecular Genetics Advance Access published online on September 30, 2004
Human Molecular Genetics, doi:10.1093/hmg/ddh288
© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030 USA
* To whom correspondence should be addressed. E-mail: jlupski{at}bcm.tmc.edu.
Smith-Magenis syndrome (SMS) is a multiple congenital anomaly/mental retardation syndrome associated with del(17)(p11.2p11.2). The phenotype is variable even in patients with deletion of the same size. RAI1 has been recently suggested as a major gene for the majority of the SMS phenotype, but its role in the full spectrum of the phenotype remains unclear. Df(11)17/+ mice contain a heterozygous deletion in the mouse region syntenic to the SMS common deletion, and exhibit craniofacial abnormalities, seizures, and marked obesity, partially reproducing the SMS phenotype. To further study the genetic basis for the phenotype, we constructed three lines of mice with smaller deletions (Df(11)17-1, Df(11)17-2, and Df(11)17-3) using retrovirus mediated chromosome engineering to create nested deletion. Both craniofacial abnormalities and obesity have been observed, but the penetrance of the craniofacial phenotype was markedly reduced in comparison to Df(11)17/+ mice. Overt seizures were not observed. Phenotypic variation has been observed in mice with the same deletion size in both the same and different genetic backgrounds, which may reflect the variation documented in the patients. These results indicate that the smaller deletions contain the gene(s), most likely Rai1, for the craniofacial abnormalities and obesity. However, genes or regulatory elements in the larger deletion that are not located in the smaller deletions, as well as genes located elsewhere, also influence both the penetrance and expressivity of the phenotype. Our mouse models refined the genomic region important for a portion of the SMS phenotype and provided a basis for further molecular analysis of genes associated with SMS.
Article
Reduced penetrance of craniofacial anomalies as a function of deletion size and genetic background in a chromosome engineered partial mouse model for Smith-Magenis syndrome
2 The Wellcome Trust Sanger Institute, Hinxton, UK
3 Department of Molecular and Human Genetics, Baylor College of Medicine, Room 604B, One Baylor Plaza, Houston, TX 77030, USA; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; Texas Children's hospital, Houston, Texas, USA
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Dierssen, Y. Herault, and X. Estivill Aneuploidy: From a Physiological Mechanism of Variance to Down Syndrome Physiol Rev, July 1, 2009; 89(3): 887 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nguyen and T. Xu The expanding role of mouse genetics for understanding human biology and disease Dis. Model. Mech., July 1, 2008; 1(1): 56 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Bi, J. Yan, X. Shi, L. A. Yuva-Paylor, B. A. Antalffy, A. Goldman, J. W. Yoo, J. L. Noebels, D. L. Armstrong, R. Paylor, et al. Rai1 deficiency in mice causes learning impairment and motor dysfunction, whereas Rai1 heterozygous mice display minimal behavioral phenotypes Hum. Mol. Genet., August 1, 2007; 16(15): 1802 - 1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Goldman, L. Potocki, K. Walz, J. K. Lynch, D. G. Glaze, J. R. Lupski, and J. L. Noebels Topical Review: Epilepsy and Chromosomal Rearrangements in Smith-Magenis Syndrome [del(17)(p11.2p11.2)] J Child Neurol, February 1, 2006; 21(2): 93 - 98. [Abstract] [PDF] |
||||
![]() |
J. L. Guenet The mouse genome Genome Res., December 1, 2005; 15(12): 1729 - 1740. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Bi, T. Ohyama, H. Nakamura, J. Yan, J. Visvanathan, M. J. Justice, and J. R. Lupski Inactivation of Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith-Magenis syndrome Hum. Mol. Genet., April 15, 2005; 14(8): 983 - 995. [Abstract] [Full Text] [PDF] |
||||




